| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 134.24B | 137.69B | 133.07B | 126.98B | 119.07B | 107.14B |
| Gross Profit | 36.09B | 36.29B | 35.93B | 34.23B | 32.71B | 28.22B |
| EBITDA | 19.23B | 20.17B | 19.12B | 18.02B | 16.88B | 13.37B |
| Net Income | 12.85B | 15.05B | 12.74B | 12.34B | 12.25B | 9.24B |
Balance Sheet | ||||||
| Total Assets | 80.83B | 89.81B | 93.61B | 90.76B | 84.98B | 82.00B |
| Cash, Cash Equivalents and Short-Term Investments | 42.30B | 52.84B | 53.01B | 52.74B | 51.03B | 49.71B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 37.24B | 41.05B | 44.83B | 43.06B | 38.26B | 36.71B |
| Stockholders Equity | 43.59B | 48.76B | 48.78B | 47.70B | 46.72B | 45.29B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 15.24B | 13.31B | 14.56B | 12.68B | 13.46B |
| Operating Cash Flow | 0.00 | 15.25B | 13.45B | 14.67B | 12.81B | 13.53B |
| Investing Cash Flow | 0.00 | 13.00M | -998.00M | -1.06B | -446.00M | -270.00M |
| Financing Cash Flow | 0.00 | -15.43B | -12.19B | -11.89B | -11.04B | -8.69B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥14.72T | 30.04 | 27.29% | 0.27% | 3.93% | 29.13% | |
74 Outperform | ¥231.28B | 15.52 | 28.98% | 5.57% | 3.47% | 18.14% | |
69 Neutral | ¥522.63B | 12.15 | 19.18% | 3.59% | 7.21% | 20.34% | |
69 Neutral | ¥107.61B | 13.95 | ― | 7.51% | -14.32% | -17.67% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
42 Neutral | ¥56.32B | -12.49 | -6.02% | 0.77% | -3.21% | -104.97% |